2424 Erwin Road, Suite 601
Durham, NC 27705
Inflammatory breast cancer; HER2+ breast cancer; development of targeted therapies; developmental therapeutics; personalized medicine
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.